Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free/oxidised sGC

Atherosclerosis

Volumn 218, Issue 2, 2011, Pages 431-434

  Ahrens, Ingo ^a,b   Habersberger, Jonathon ^a,c   Baumlin, Nadège ^a   Qian, Hongwei ^a   Smith, Belinda K ^a,c   Stasch, Johannes Peter ^d   Bode, Christoph ^b   Schmidt, Harald H H W ^c,e   Peter, Karlheinz ^a,c  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MONASH UNIVERSITY   (Australia)

^d BAYER PHARMA AG   (Germany)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

BAY 58 2667; Cinaciguat; Coronary artery disease; Oxidative stress; Platelets; SGC

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CINACIGUAT; GUANYLATE CYCLASE; PADGEM PROTEIN; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME METABOLISM; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

AGED; BENZOIC ACIDS; BLOOD PLATELETS; CELL ADHESION MOLECULES; CORONARY ARTERY DISEASE; FEMALE; GUANYLATE CYCLASE; HEME; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MODELS, BIOLOGICAL; OXIDATIVE STRESS; OXYGEN; P-SELECTIN; PHOSPHOPROTEINS; PHOSPHORYLATION;

EID: 80053272815     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.06.042     Document Type: Article

References (16)

1. Stasch J.P., Schmidt P.M., Nedvetsky P.I., et al. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest 2006, 116:2552-2561.
2. Evgenov O.V., Pacher P., Schmidt P.M., Hasko G., Schmidt H.H., Stasch J.P. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 2006, 5:755-768.
3. Stasch J.P., Pacher P., Evgenov O.V. Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation 2011, 123:2263-2273.
4. Roy B., Mo E., Vernon J., Garthwaite J. Probing the presence of the ligand-binding haem in cellular nitric oxide receptors. Br J Pharmacol 2008, 153:1495-1504.
5. Boerrigter G., Costello-Boerrigter L.C., Cataliotti A., Lapp H., Stasch J.P., Burnett J.C. Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure. Hypertension 2007, 49:1128-1133.
6. Lapp H., Mitrovic V., Franz N., et al. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. Circulation 2009, 119:2781-2788.
7. Walter U., Gambaryan S. cGMP and cGMP-dependent protein kinase in platelets and blood cells. Handb Exp Pharmacol 2009, 533-548.
8. Gambaryan S., Kobsar A., Hartmann S., et al. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost 2008, 6:1376-1384.
9. Brune B., Schmidt K.U., Ullrich V. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem 1990, 192:683-688.
10. Miller F.J., Gutterman D.D., Rios C.D., Heistad D.D., Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998, 82:1298-1305.
11. Heistad D.D. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol 2006, 26:689-695.
12. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
13. Chirkov Y.Y., Holmes A.S., Chirkova L.P., Horowitz J.D. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation 1999, 100:129-134.
14. Chirkov Y.Y., Holmes A.S., Willoughby S.R., et al. Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. J Am Coll Cardiol 2001, 37:1851-1857.
15. Jensen B.O., Selheim F., Doskeland S.O., Gear A.R., Holmsen H. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide. Blood 2004, 104:2775-2782.
16. Martin F., Baskaran P., Ma X., et al. Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase. J Biol Chem 2010, 285:22651-22657.